Feng Feng

Prof. Feng Feng


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Theranostics
Verified
Journal Article
Open access
MSMangmang Sang
Mangmang Sang
RLRenjie Luo
Renjie Luo
YBYidan Bai
Yidan Bai
JDJun Dou
Jun Dou
ZZZhongtao Zhang
Zhongtao Zhang
WLwenyuan liu
wenyuan liu
Rationale: Ferroptosis is a regulated process of cell death caused by iron-dependent accumulation of lipid hydroperoxides (LPO). It is sensitive to epithelial-to-mesenchymal transition (EMT) cells, a well-known therapy-resistant state of cancer. Previous studies on nanomaterials did not investigate the immense value of ferroptosis therapy (FT) in epithelial cell carcinoma during EMT. Herein, we describe an EMT-specific nanodevice for a comprehensive FT strategy involving LPO burst.

1 January 2018 in Theranostics
Verified
Journal Article
Open access
HLHuan Liang
Huan Liang
ZZZhanwei Zhou
Zhanwei Zhou
RLRenjie Luo
Renjie Luo
MSMangmang Sang
Mangmang Sang
BLBowen Liu
Bowen Liu
WLwenyuan liu
wenyuan liu
Photodynamic therapy relies on photosensitizers to generate cytotoxic reactive oxygen species (ROS) resulting in the apoptois of tumor cells. However, there is an antioxidant system that impedes the elevation of oxidation levels in tumor cells. Thus, photodynamic therapy may exhibit insufficient curative effects due to ungenerous reactive oxygen species levels. Herein, we describe tumor-specific activated photodynamic therapy using an oxidation-regulating strategy.

20 February 2019 in Organic Letters
Verified
Journal Article
Closed access
MCMinghua Chen
Minghua Chen
RWRenzhong Wang
Renzhong Wang
WZWuli Zhao
Wuli Zhao
LYLiyan Yu
Liyan Yu
CZConghui Zhang
Conghui Zhang
SSShuyi Si
Shuyi Si

23 October 2019 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
MSMangmang Sang
Mangmang Sang
LHLingfei Han
Lingfei Han
RLRenjie Luo
Renjie Luo
WQWei Qu
Wei Qu
FZFeng Zheng
Feng Zheng
FFFeng Feng
Feng Feng
Gambogic acid (GA) is a natural anti-tumor drug whose application is restricted by its poor aqueous solubility and inefficient bioavailability. Developing nanomaterials with excellent biocompatibility can amplify the therapeutic effects of GA. In this study, a tumor-targeted redox controllable self-assembled nano-system with magnetic enhanced EPR effects (mPEG-HA/CSO-SS-Hex/SPION/GA) was developed to improve the anticancer efficacy of GA. The nano-system is constituted by three layers: the outer layer is mono-aminated poly(ethylene glycol) grafted hyaluronic acid (mPEG-HA), which can target the CD44 receptor in breast cancer cells; the middle layer consists of disulfide linked hexadecanol (Hex) and chitosan oligosaccharide (CSO) to control the drug release by reduction response; the core layer is superparamagnetic iron oxide nanoparticles (SPION), which can enhance the EPR effect by magnetic guidance and contribute to GA entrapment. Different experiments were performed to characterize the complex self-assembly, and the cytotoxicity, pharmacokinetics, and in vivo antitumor activity of the self-assembly were investigated to evaluate its anti-tumor effects. The results revealed that mPEG-HA/CSO-SS-Hex/SPION/GA is an excellent nanosystem with appropriate size and sensitive responsiveness; it can accumulate in tumor sites and achieve excellent therapeutic effects on triple-negative breast cancer (TNBC). In summary, a CD44-targeted redox-triggered self-assembly nanosystem with magnetic enhanced EPR effects was developed for effective amplification of GA; it has potential to act as an effective carrier in drug delivery for chemotherapy of TNBC.

1 November 2019 in Bioorganic Chemistry
Verified
Journal Article
Closed access
JXJian-Qi Xiao
Jian-Qi Xiao
WLWen-Yuan Liu
Wen-Yuan Liu
HSHaopeng Sun
Haopeng Sun
Wei LiWei Li
Wei Li
KKKazuo Koike
Kazuo Koike
JZJie Zhang
Jie Zhang

1 April 2019 in Phytomedicine
Verified
Journal Article
Closed access
LCLei Chen
Lei Chen
PJPan Jiang
Pan Jiang
JLJinsong Li
Jinsong Li
ZXZijian Xie
Zijian Xie
YXYunhui Xu
Yunhui Xu
WLwenyuan liu
wenyuan liu